A previous study reported that PLEKHA5 was associated with decreased brain metastasis-free survival but not associated with other metastatic sites in melanoma patients, and knockdown of PLEKHA5 inhibited blood–brain barrier transmigration and invasion of cells in in vitro models64. This evidence concerns the gene PLEKHA5 and melanoma.